World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
17826
World Ranking
3672
National Ranking
321

Rainer Doffinger publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rainer Doffinger sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 178 publications — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rainer Doffinger D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rainer Doffinger sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Rainer Doffinger is a researcher affiliated with the University of Cambridge in the United Kingdom. Their scientific work primarily centers on the field of Medicine, with a particular focus on Infectious Diseases, Immunology, Neurology, Genetics, and Molecular Biology. The main topics in their research portfolio include SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, immunodeficiency and autoimmune disorders, long-term effects of COVID-19, T-cell and B-cell immunology, SARS-CoV-2 detection and testing, and immune cell function and interaction.

Doffinger has contributed to numerous publications that address various aspects of SARS-CoV-2 and immune system responses. Notable recent papers include:

  • A thermostable, closed SARS-CoV-2 spike protein trimer (2020, Nature Structural & Molecular Biology)
  • Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease (2021, Immunity)
  • Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies (2021, bioRxiv (Cold Spring Harbor Laboratory))
  • Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report (2020, Nature Communications)

The frequent publication venues for Doffinger's work highlight involvement in both preprint and peer-reviewed settings, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Immunology
  • Research Square (Research Square)
  • Nature Communications
  • Frontiers in Immunology

Collaboration forms a significant part of Doffinger's research activities. Frequent co-authors include John R. Bradley, Lourdes Ceron-Gutierrez, Kenneth G. C. Smith, Ravindra K. Gupta, and Nathalie Kingston, reflecting ongoing partnerships within the immunology and infectious disease research communities.

Best Publications

  • Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

    Frédéric Altare;Anne Durandy;David Lammas;Jean-François Emile

  • SARS-CoV-2 evolution during treatment of chronic infection.

    Steven A. Kemp;Dami A. Collier;Dami A. Collier;Rawlings P. Datir;Isabella A. T. M. Ferreira

  • X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.

    Rainer Döffinger;Asma Smahi;Christine Bessia;Frédéric Geissmann

  • A robust model for read count data in exome sequencing experiments and implications for copy number variant calling

    Vincent Plagnol;James Curtis;Michael Epstein;Kin Y. Mok

  • Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2.

    Dami A Collier;Dami A Collier;Isabella A T M Ferreira;Prasanti Kotagiri;Rawlings P Datir;Rawlings P Datir

  • A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

    Emmanuelle Jouanguy;Salma Lamhamedi-Cherradi;David Lammas;Susan E. Dorman

  • Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage

    Ivan Angulo;Oscar Vadas;Fabien Garçon;Edward Banham-Hall

  • Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

    Anne Puel;Anne Puel;Rainer Döffinger;Angels Natividad;Angels Natividad;Maya Chrabieh;Maya Chrabieh

  • IRF8 mutations and human dendritic-cell immunodeficiency.

    Sophie Hambleton;Sandra Salem;Jacinta Bustamante;Venetia Bigley

  • Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.

    Dami A. Collier;Dami A. Collier;Anna De Marco;Isabella A. T. M. Ferreira;Bo Meng

  • Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection.

    F Altare;D Lammas;P Revy;E Jouanguy

  • Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency

    Capucine Picard;Capucine Picard;Horst Von Bernuth;Horst Von Bernuth;Horst Von Bernuth;Pegah Ghandil;Pegah Ghandil;Pegah Ghandil;Maya Chrabieh;Maya Chrabieh

  • IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men.

    Emmanuelle Jouanguy;Rainer Döffinger;Stéphanie Dupuis;Annaïck Pallier

  • Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

    Tanya I Coulter;Anita Chandra;Chris M Bacon;Judith Babar

  • Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries

    Ludovic de Beaucoudrey;Arina Samarina;Arina Samarina;Arina Samarina;Jacinta Bustamante;Jacinta Bustamante;Aurélie Cobat;Aurélie Cobat

  • A hypermorphic IκBα mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency

    Gilles Courtois;Asma Smahi;Janine Reichenbach;Rainer Döffinger

  • The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88

    Bing He;Raul Santamaria;Weifeng Xu;Montserrat Cols

  • The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency

    Venetia Bigley;Muzlifah Haniffa;Sergei Doulatov;Xiao-Nong Wang

  • The NF-κB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes

    Asma Smahi;Gilles Courtois;Smail Hadj Rabia;Rainer Döffinger

  • Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.

    Laura Bergamaschi;Federica Mescia;Lorinda Turner;Aimee L. Hanson

  • A thermostable, closed SARS-CoV-2 spike protein trimer.

    Xiaoli Xiong;Kun Qu;Katarzyna A. Ciazynska;Myra Hosmillo

  • Mutations in the selenocysteine insertion sequence–binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans

    Erik Schoenmakers;Maura Agostini;Catherine Mitchell;Nadia Schoenmakers

  • Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity.

    Rainer Döffinger;Matthew R. Helbert;Gabriela Barcenas-Morales;Kun Yang

  • Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3.

    Emma M. Haapaniemi;Meri Kaustio;Hanna L. M. Rajala;Arjan J. van Adrichem

  • IRAK-4-and MyD88-Dependent Pathways Are Essential for the Removal of Developing Autoreactive B Cells in Humans

    Isabelle Isnardi;Yen Shing Ng;Iva Srdanovic;Roja Motaghedi

  • Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion.

    Stéphanie Dupuis;Rainer Döffinger;Capucine Picard;Claire Fieschi

Frequent Co-Authors

Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Mario Abinun
Mario Abinun Newcastle University
Siobhan O. Burns
Siobhan O. Burns University College London
Kenneth G. C. Smith
Kenneth G. C. Smith Walter and Eliza Hall Institute of Medical Research
Sinisa Savic
Sinisa Savic University of Leeds
Andrew J. Cant
Andrew J. Cant Newcastle University
Adrian J. Thrasher
Adrian J. Thrasher University College London
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Ian Goodfellow
Ian Goodfellow University of Cambridge
Capucine Picard
Capucine Picard Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring immunology opens doors to diverse healthcare roles, including advanced nursing specialties that complement scientific expertise. For those interested in nursing pathways, programs such as cheap psych np programs offer accessible routes to becoming a psychiatric nurse practitioner. These online options help balance cost and quality education, making advanced practice degrees attainable.

Career growth is also influenced by specialization. According to recent data, some of the highest paid dnp specialties include areas closely connected with immunology, such as acute care and psychiatric nursing. Understanding salary trends can guide students towards rewarding career choices aligned with their interests.

For nurse practitioners aiming to refine their expertise, earning an acute care certification for fnp is a strategic move. This certification offers a pathway to advanced clinical roles that often intersect with immunology, especially in critical care settings.

Additionally, those looking to expedite their qualifications may consider an accelerated fnp program. These programs provide intensive training for Family Nurse Practitioners, enabling faster entry into the field and allowing graduates to integrate immunology knowledge into primary care practice.

Best Scientists Citing Rainer Doffinger

Trending Scientists

Recently Published Articles